Log In
Print
BCIQ
Print
Print this Print this
 

AMG 557

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionHuman mAb targeting B7 related protein (B7RP-1)
Molecular Target B7 related protein 1 (B7RP-1)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationLupus
Indication DetailsTreat systemic lupus erythematosus (SLE)
Regulatory Designation
Partner AstraZeneca plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$50.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today